Biogen Increases Full-Year Forecast After Profit Surges

Biogen Idec Inc., the fourth-largest U.S. biotechnology company by market value, raised its full-year forecast after first-quarter net income increased on a tax benefit.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.